GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » EV-to-FCF

PT Indofarma Tbk (ISX:INAF) EV-to-FCF : -5.56 (As of May. 28, 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Indofarma Tbk's Enterprise Value is Rp1,394,712 Mil. PT Indofarma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was Rp-250,700 Mil. Therefore, PT Indofarma Tbk's EV-to-FCF for today is -5.56.

The historical rank and industry rank for PT Indofarma Tbk's EV-to-FCF or its related term are showing as below:

ISX:INAF' s EV-to-FCF Range Over the Past 10 Years
Min: -1020.33   Med: -13.13   Max: 8178.55
Current: -5.66

During the past 13 years, the highest EV-to-FCF of PT Indofarma Tbk was 8178.55. The lowest was -1020.33. And the median was -13.13.

ISX:INAF's EV-to-FCF is ranked worse than
100% of 528 companies
in the Drug Manufacturers industry
Industry Median: 24.695 vs ISX:INAF: -5.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), PT Indofarma Tbk's stock price is Rp280.00. PT Indofarma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was Rp-141.024. Therefore, PT Indofarma Tbk's PE Ratio for today is At Loss.


PT Indofarma Tbk EV-to-FCF Historical Data

The historical data trend for PT Indofarma Tbk's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk EV-to-FCF Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.61 166.44 390.27 99.31 -30.80

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 231.93 -30.80 -32.04 -15.96 -8.16

Competitive Comparison of PT Indofarma Tbk's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's EV-to-FCF falls into.



PT Indofarma Tbk EV-to-FCF Calculation

PT Indofarma Tbk's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1394712.144/-250700.087
=-5.56

PT Indofarma Tbk's current Enterprise Value is Rp1,394,712 Mil.
PT Indofarma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-250,700 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Indofarma Tbk  (ISX:INAF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PT Indofarma Tbk's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=280.00/-141.024
=At Loss

PT Indofarma Tbk's share price for today is Rp280.00.
PT Indofarma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-141.024.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PT Indofarma Tbk EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines